Cargando…
Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study
BACKGROUND: Fibroblast growth factor 23 is an emerging vascular biomarker, recently associated with cerebral small vessel disease and poor cognition in patients on dialysis. It also interacts with klotho, an anti-aging and cognition enhancing protein. OBJECTIVE: To determine if circulating Fibroblas...
Autores principales: | McGrath, Emer R., Himali, Jayandra J., Levy, Daniel, Conner, Sarah C., Pase, Matthew P., Abraham, Carmela R., Courchesne, Paul, Satizabal, Claudia L., Vasan, Ramachandran S., Beiser, Alexa S., Seshadri, Sudha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398923/ https://www.ncbi.nlm.nih.gov/pubmed/30830941 http://dx.doi.org/10.1371/journal.pone.0213321 |
Ejemplares similares
-
Circulating IGFBP‐2: a novel biomarker for incident dementia
por: McGrath, Emer R., et al.
Publicado: (2019) -
Identifying Blood Biomarkers for Dementia Using Machine Learning Methods in the Framingham Heart Study
por: Lin, Honghuang, et al.
Publicado: (2022) -
Growth Differentiation Factor 15 and NT‐proBNP as Blood‐Based Markers of Vascular Brain Injury and Dementia
por: McGrath, Emer R., et al.
Publicado: (2020) -
Secular Trends in Head Size and Cerebral Volumes In the Framingham Heart Study for Birth Years 1902–1985
por: DeCarli, Charles, et al.
Publicado: (2023) -
Overweight, Obesity, and Survival After Stroke in the Framingham Heart Study
por: Aparicio, Hugo J., et al.
Publicado: (2017)